← Browse by Condition
Medical Condition

telerehabilitation

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for telerehabilitation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — telerehabilitation Clinical Trials

How many clinical trials are currently recruiting for telerehabilitation?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for telerehabilitation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for telerehabilitation?
telerehabilitation research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a telerehabilitation clinical trial?
Eligibility criteria for telerehabilitation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Zhongshan People's Hospital, Guangdong, China 1 trial
Kuopio University Hospital 1 trial
Foundation University Islamabad 1 trial

Recruiting Clinical Trials

NCT05990946
Recruiting
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
Enrollment
736 pts
Location
China
Sponsor
Zhongshan People's Hospital, G...
View Trial →
NCT07795697
Recruiting
Telerehabilitation After Spine Surgery
Enrollment
300 pts
Location
Finland
Sponsor
Kuopio University Hospital
View Trial →
NCT07803003
Recruiting
Effects of Maximum Versus Minimum Supervised Telerehabilitation on Upper Limb Function in Post Stroke Patients
Enrollment
30 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
View Trial →

Related Conditions

lung neoplasms non small cell lung cancer (1) postoperative complications (1) patient reported outcome measures (1) exercise therapy (1) spine surgery (1) low back pain (1) stroke (1) upper limb (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology